Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giulia Orsi

Showing results (11-20 of 60) with videos related to

Pageof 6
Sort By:
Critical Reviews in Oncology/Hematology|February 28, 2018
Resistance to EGFR inhibitors in non-small cell lung cancer: Clinical management and future perspectivesChiara Tomasello, Cinzia Baldessari, Martina Napolitano, et al.
Journal of Gastrointestinal Cancer|March 7, 2023
The Role of Neoadjuvant FOLFIRINOX in Borderline Resectable Pancreatic Cancer: A Network Meta-AnalysisFausto Petrelli, Michele Ghidini, Marina Macchini, et al.
Thoracic Cancer|April 7, 2017
Secondary biopsy of non-oncogenic-driven lung cancer may reveal a clinically sensible histologic change. A brief report of two paradigmatic casesMaria C Mengoli, Giulia Orsi, Filippo Lococo, et al.
Cancer Treatment Reviews|August 21, 2021
Treatment opportunities and future perspectives for pancreatic cancer patients with germline BRCA1-2 pathogenic variantsMarina Macchini, Federico Centonze, Umberto Peretti, et al.
Cancer Treatment Reviews|February 20, 2022
Epidemiology and geographic distribution of BRCA1-2 and DNA Damage response genes pathogenic variants in pancreatic ductal adenocarcinoma patientsMarina Macchini, Federico Centonze, Umberto Peretti, et al.
Molecular and Clinical Oncology|December 10, 2019
Immunohistochemical mismatch repair proteins expression as a tool to predict the melanoma immunotherapy responseGiovanni Ponti, Giovanni Pellacani, Aldo Tomasi, et al.
Cancer Gene Therapy|June 30, 2018
Inducible Caspase9-mediated suicide gene for MSC-based cancer gene therapyFilippo Rossignoli, Giulia Grisendi, Carlotta Spano, et al.
Journal of Hepatology|August 27, 2019
Management of adverse events with tailored sorafenib dosing prolongs survival of hepatocellular carcinoma patientsFrancesco Tovoli, Luca Ielasi, Andrea Casadei-Gardini, et al.
Methods and Protocols|April 27, 2026
Management of Patients with Suspected Hypersensitivity to Chemotherapy Drugs: A Practical Approach in a Tertiary Care SettingMaria Bernadette Cilona, Serena Nannipieri, Arianna Ferlito, et al.
Clinical Colorectal Cancer|March 21, 2020
Is There an Optimal Choice in Refractory Colorectal Cancer? A Network Meta-AnalysisAndrea Casadei-Gardini, Alessandro Vagheggini, Fabio Gelsomino, et al.
Pageof 6

Showing results (11-20 of 60) with videos related to

Sort By:
Pageof 6
Critical Reviews in Oncology/Hematology|February 28, 2018
Resistance to EGFR inhibitors in non-small cell lung cancer: Clinical management and future perspectivesChiara Tomasello, Cinzia Baldessari, Martina Napolitano, et al.
Journal of Gastrointestinal Cancer|March 7, 2023
The Role of Neoadjuvant FOLFIRINOX in Borderline Resectable Pancreatic Cancer: A Network Meta-AnalysisFausto Petrelli, Michele Ghidini, Marina Macchini, et al.
Thoracic Cancer|April 7, 2017
Secondary biopsy of non-oncogenic-driven lung cancer may reveal a clinically sensible histologic change. A brief report of two paradigmatic casesMaria C Mengoli, Giulia Orsi, Filippo Lococo, et al.
Cancer Treatment Reviews|August 21, 2021
Treatment opportunities and future perspectives for pancreatic cancer patients with germline BRCA1-2 pathogenic variantsMarina Macchini, Federico Centonze, Umberto Peretti, et al.
Cancer Treatment Reviews|February 20, 2022
Epidemiology and geographic distribution of BRCA1-2 and DNA Damage response genes pathogenic variants in pancreatic ductal adenocarcinoma patientsMarina Macchini, Federico Centonze, Umberto Peretti, et al.
Molecular and Clinical Oncology|December 10, 2019
Immunohistochemical mismatch repair proteins expression as a tool to predict the melanoma immunotherapy responseGiovanni Ponti, Giovanni Pellacani, Aldo Tomasi, et al.
Cancer Gene Therapy|June 30, 2018
Inducible Caspase9-mediated suicide gene for MSC-based cancer gene therapyFilippo Rossignoli, Giulia Grisendi, Carlotta Spano, et al.
Journal of Hepatology|August 27, 2019
Management of adverse events with tailored sorafenib dosing prolongs survival of hepatocellular carcinoma patientsFrancesco Tovoli, Luca Ielasi, Andrea Casadei-Gardini, et al.
Methods and Protocols|April 27, 2026
Management of Patients with Suspected Hypersensitivity to Chemotherapy Drugs: A Practical Approach in a Tertiary Care SettingMaria Bernadette Cilona, Serena Nannipieri, Arianna Ferlito, et al.
Clinical Colorectal Cancer|March 21, 2020
Is There an Optimal Choice in Refractory Colorectal Cancer? A Network Meta-AnalysisAndrea Casadei-Gardini, Alessandro Vagheggini, Fabio Gelsomino, et al.
Pageof 6